Scinai Immunotherapeutics (SCNI) Stock: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$2.44
0.78 (46.99%)
â˛
5d:
+31.18%
30d:
+916.67%
90d:
+637.16%
WAIT
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Sep 09, 2026
0d
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SCNI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SCNI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $2.44, which is considered slightly high relative to its 30-day fair value range of $0.39 to $2.60.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $1.60, while resistance sits at $2.70. The stock is showing strong short-term momentum, up 47.0% recently.
Market Sentiment: SCNI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $700.00 (+28588.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $1.60, while resistance sits at $2.70. The stock is showing strong short-term momentum, up 47.0% recently.
Market Sentiment: SCNI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $700.00 (+28588.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.39 -
$2.60
Company Quality Score
37/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: Strong upward momentum (+47.0%)
- BULLISH: Trading 28588.5% below Wall St target ($700.00)
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.39 -
$2.60
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.60
Resistance Level
$2.70
Current Trend
Uptrend
Technical data as of
Sep 14, 2026
Fundamental Context
Wall Street Target
$700.00
(+28588.5%)
Revenue Growth (YoY)
146.0%
Earnings Growth (YoY)
87.2%
Profit Margin
-174.8%
Share & Embed Analysis
Last updated: September 14, 2026 11:10 PM ET
Data refreshes hourly during market hours. Next update: 12:10 AM
Data refreshes hourly during market hours. Next update: 12:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 48 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 49 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 48 HOLD |